Bioaftogen O+A+SAT2

About this veterinary medicine

Bioaftogen O+A+SAT2 is a veterinary medicine in the form of emulsion injectable containing virus inactivé de la fièvre aphteuse. It is marketed by Biogénesis Bagó S.A. Argentina. It holds a marketing authorisation in Tunisia under number 1286.1614.25.

Characteristics

Form

Emulsion injectable

Strength

0,6 ml/2ml

Presentation

Flacon d'un volume nominal de 50 ml

Route of administration

Injectable route

Laboratory

Biogénesis Bagó S.A. Argentina

Country

Argentina

Regulatory status — Tunisie

🟢 Marketing authorisation in force

Authorisation no. : 1286.1614.25 — Authorisation date : 14/07/2025

⚠️ Regulatory alerts

No alert reported.

📦 Availability in Tunisia

Reported by TunisieVet veterinarians.

🔒 Availability reporting is reserved for signed-in veterinarians.